Dr. Charlotte Bekker is a biomedical scientist and Assistant Professor at the Department of Pharmacy, Pharmacology and Toxicology, at Radboudumc, the Netherlands. Her research focuses on making medication use more sustainable by improving patient outcomes while reducing waste, environmental impact, and unnecessary healthcare costs. Currently, she leads projects aimed at preventing medication waste, enabling the safe redispensing of unused medicines, supporting medication adherence, and exploring patient-guided dose reduction through shared decision making.

 Charlotte chairs the Dutch Green Deal Sustainable Healthcare Goals for medications in the Netherlands. She works across diverse patient populations, including oncology, hematology, and rheumatology, and collaborates with all stakeholder of the pharmaceutical supply chain. Her interdisciplinary approach combines quantitative and qualitative research methods, implementation science, and eHealth technologies to effectively translate evidence into real-world impact.

Björn Wettermark, M.Sc.Pharm, PhD is Professor of Pharmacoepidemiology at Uppsala University, Sweden and visiting Professor at Vilnius University, Lithuania. His research focuses on drug utilization as a tool in health policy including prescribing quality indicators, international comparisons of drug utilization, evaluation of prescribing doctors´ adherence to guidelines, evidence generation for new medicines and patient adherence to treatment.

Prof. Wettermark has previously had various managerial positions in the health region of Stockholm as well as other commitments including membership in national and regional strategic groups on medicine management, scientific advisor to the Swedish Medical Products Agency and Chair of the European Drug Utilization Research group (EuroDURG), the European chapter of the International Society for Pharmacoepidemiology.